IRD Opus Genetics trades modestly higher post Q4 2025 earnings despite wider than expected per share losses XPO XPO notches 134 percent Q4 2025 EPS beat even as shares dip slightly in todays trading Is Teva TEVA stock trading above fair range Q4 2025 EPS Tops Views